Over the weekend, news broke that Merus N.V. $MRUS is being acquired by Genmab $GMAB for $97 per share. The stock closed Friday at $69, sitting at the upper end of a more than two-month sideways consolidation.
Nike reports tonight. Here's how they got into this mess.
Nike's investor relations homepage features a Mission Statement that all but screams written by committee. “Nike, Inc. is a Growth Company,” it declares, “We create innovative, must-have products. We build deep, personal...
Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily...
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
Speculative growth is back in the driver’s seat with the flagship ARK fund kicking off the week with fresh cycle highs on both absolute and relative terms.
We’ve been leaning back into this theme since early September, and...
